title: Comparative analysis of the behavioral and biomolecular parameters of four mouse strains.
abstract: The use of mice as experimental models in pharmacological and biochemical research began over 100 years ago, during which time different mice strains with specific features were developed. Numerous studies demonstrate that the pharmacological efficacy of various compounds significantly varies among different animal strains, a factor which must be considered when analyzing experimental data. The Sabra strain, developed more than 35 years ago, is widely used for research in Israel but has an unclear origin and is not characterized as well as other strains. Comparative analyses of the molecular characteristics of Sabra and other strains should help to understand their characteristics and to enhance the validity of their experimental use. Thus, four mouse strains-outbred ICR and Sabra as well as inbred C57Bl/6J and Balb/c were compared. Animals' weight, blood corticosterone and hippocampal BDNF mRNA levels were measured, and animals' behavior was compared using the EPM, open field, FST, and hot plate tests. We found that although Sabra mice are bigger and heavier than other tested lines, this is not reflected in behavior or in biomolecular features, wherein Sabra mice lay within the diapason of other tested animals. Thus, behavioral tests of anxiety-like behavior and locomotor activity revealed that Sabra mice scored close to the mean of all tested lines. Analysis of blood corticosterone levels did not show significant differences among tested strains. We also found a correlation between general and locomotor activity of the tested strains and their hippocampal BDNF mRNA expression. In summary, we may conclude that Sabra mice have traits similar to the better known lines, and therefore they are good subjects for neuroscience research.
authors: Department of Molecular Biology, Ariel University Center of Samaria, Ariel, 40700, Israel.
authors: Elimelech
authors: E
authors: Nesher
authors: Vladimir
authors: V
authors: Peskov
authors: Anna
authors: A
authors: Rylova
authors: Olga
authors: O
authors: Raz
authors: Albert
authors: A
authors: Pinhasov
references: Eur J Nutr. 2000 Feb;39(1):18-30
references: 10900554
references: J Affect Disord. 2010 Oct;126(1-2):214-22
references: 20427092
references: Nat Protoc. 2007;2(2):322-8
references: 17406592
references: Eur J Pharmacol. 2003 Feb 7;461(1):27-34
references: 12568912
references: Anim Behav. 1973 May;21(2):205-35
references: 4578750
references: Physiol Behav. 2001 Aug;73(5):705-17
references: 11566205
references: J Mol Neurosci. 2008 Nov;36(1-3):330-8
references: 18592413
references: Neuropsychopharmacology. 2009 Mar;34(4):1057-66
references: 18843267
references: J Pharmacol Exp Ther. 1995 Feb;272(2):699-707
references: 7853184
references: Neuropeptides. 2010 Dec;44(6):509-14
references: 20971507
references: J Pain. 2009 Jul;10(7):767-73
references: 19409860
references: Behav Processes. 2002 Nov;60(2):181-190
references: 12426069
references: Behav Genet. 2000 Mar;30(2):101-9
references: 10979600
references: Pharmacol Biochem Behav. 2001 Mar;68(3):435-41
references: 11325396
references: Eur J Pharmacol. 2007 Jan 12;554(2-3):155-63
references: 17116301
references: Neurosci Biobehav Rev. 1998;22(1):33-57
references: 9491939
references: Behav Brain Res. 2007 Feb 27;177(2):254-60
references: 17204340
references: Psychopharmacology (Berl). 2005 Jan;177(3):245-55
references: 15609067
references: Free Radic Biol Med. 1996;20(3):421-32
references: 8720914
references: J Ethnopharmacol. 2008 Jul 23;118(2):312-7
references: 18539420
references: J Pharmacol Exp Ther. 2007 Aug;322(2):646-53
references: 17478614
references: Arthritis Rheum. 2004 Mar;50(3):985-98
references: 15022343
references: J Neurosci Methods. 1985 Aug;14(3):149-67
references: 2864480
references: Behav Processes. 2006 Mar;72(1):104-12
references: 16442749
references: Behav Brain Res. 2002 Aug 21;134(1-2):49-57
references: 12191791
references: Psychopharmacology (Berl). 2001 May;155(3):315-22
references: 11432695
references: Genes Brain Behav. 2005 Feb;4(1):60-4
references: 15660669
references: Eur J Neurosci. 1997 Sep;9(9):1950-60
references: 9383218
references: Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S208-16
references: 19541429
references: Nutr Neurosci. 2003 Jun;6(3):197-9
references: 12793525
references: J Psychiatr Res. 2010 Oct;44(13):808-16
references: 20172535
references: Pharmacol Biochem Behav. 1996 May;54(1):21-30
references: 8728535
references: Lab Anim. 1973 May;7(2):135-8
references: 4712302
references: J Neurochem. 2008 Apr;105(1):1-17
references: 18208542
references: CNS Drugs. 2010 Jan;24(1):1-7
references: 20030415
references: Psychopharmacology (Berl). 1997 Jul;132(2):107-24
references: 9266608
references: Pharmacol Biochem Behav. 2001 May-Jun;69(1-2):35-40
references: 11420066
references: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1590-4
references: 18582526
references: J Control Release. 2002 Apr 23;80(1-3):1-7
references: 11943383
references: Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36
references: 596982
references: Behav Brain Res. 2004 Apr 2;150(1-2):25-32
references: 15033276
references: Genes Brain Behav. 2010 Jun 1;9(4):379-89
references: 20132316
references: Physiol Behav. 2001 Jan;72(1-2):271-81
references: 11240006
references: Comp Med. 2005 Aug;55(4):326-34
references: 16158908
references: J Neurosci Methods. 2008 Jun 15;171(1):48-52
references: 18358538
references: Genes Brain Behav. 2005 Jul;4(5):307-17
references: 16011577
references: Brain Res Bull. 2005 Mar 15;65(2):117-23
references: 15763177
references: In Vivo. 1995 Mar-Apr;9(2):155-62
references: 7548792
references: Biol Psychiatry. 2008 Nov 15;64(10):884-90
references: 18675955